Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00120809
What this trial is testing

Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 3,000
Post-approval studies (Phase 4)UnknownNCT03726593
What this trial is testing

Drug Combinations of Atovaquone-Proguanil (AP) With ACT

Who this might be right for
Plasmodium Falciparum Malaria (Drug Resistant)
Armed Forces Research Institute of Medical Sciences, Thailand 252
Early research (Phase 1)Study completedNCT00374998
What this trial is testing

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Who this might be right for
Malaria, FalciparumMalaria
European Vaccine Initiative 35
Very early researchStudy completedNCT00719602
What this trial is testing

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Who this might be right for
HIV InfectionsMalaria
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 105
Early research (Phase 1)Study completedNCT00513669
What this trial is testing

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

Who this might be right for
Falciparum Malaria
Swiss Tropical & Public Health Institute 50
Testing effectiveness (Phase 2)Study completedNCT02909712
What this trial is testing

Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania

Who this might be right for
MalariaPregnancy MalariaCardiotoxicity+2 more
London School of Hygiene and Tropical Medicine 201
Post-approval studies (Phase 4)Study completedNCT02084602
What this trial is testing

Assessment of Artesunate/Mefloquine in the Peruvian Amazon

Who this might be right for
Malaria, Falciparum
Instituto Nacional de Salud. Peru 45
Not applicableLooking for participantsNCT07389057
What this trial is testing

Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

Who this might be right for
Malaria Asymptomatic ParasitaemiaMalaria FalciparumMalaria Infection+1 more
Noguchi Memorial Institute for Medical Research 9,000
Early research (Phase 1)Study completedNCT01988636
What this trial is testing

Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 296
Not applicableStudy completedNCT02793336
What this trial is testing

Early Life Cohort in Papua Indonesia (ELIPI Study)

Who this might be right for
Malaria
Menzies School of Health Research 500
Not applicableStudy completedNCT00314899
What this trial is testing

Fetal Immunity to Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 500
Large-scale testing (Phase 3)Study completedNCT02699099
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 699
Large-scale testing (Phase 3)Study completedNCT00623857
What this trial is testing

Micronutrients and Child Health Study

Who this might be right for
Malaria
Wageningen University 612
Early research (Phase 1)Study completedNCT02942277
What this trial is testing

Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 301
Not applicableStudy completedNCT00725777
What this trial is testing

Treatment of Non-falciparum Malaria

Who this might be right for
Acute Non-falciparum Malaria
Albert Schweitzer Hospital 40
Post-approval studies (Phase 4)UnknownNCT02414399
What this trial is testing

Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children

Who this might be right for
PneumoniaDiarrheaMalaria+3 more
University of Washington 1,400
Not applicableStudy completedNCT00466557
What this trial is testing

Plasmodium Resistance in A. Gambiae

Who this might be right for
MalariaPlasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT02329301
What this trial is testing

Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia

Who this might be right for
MalariaMalaria, Falciparum
PATH 2,430
Large-scale testing (Phase 3)Looking for participantsNCT06923592
What this trial is testing

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Who this might be right for
Malaria VivaxMalaria FalciparumPlasmodium Vivax+1 more
London School of Hygiene and Tropical Medicine 19,200
Not applicableUnknownNCT03594084
What this trial is testing

Malaria in Strasbourg University Hospital

Who this might be right for
Malaria
University Hospital, Strasbourg, France 70
Next Page